Schedule 13G ownership disclosure

AVADEL PHARMACEUTICALS PLC

Security class unavailable · CUSIP: 05337M104

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-22-000274
Form type
SC 13G/A
Filer
AVADEL PHARMACEUTICALS PLC
CIK
CIK 1012477
Filed
Jan 21, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub